D. E. Shaw & Co., Inc. Chemo Centryx, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Shares

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $836,052 - $1.95 Million	37,711 Added 423.34%	46,619 $2.41 Million
Q2 2022 Aug 15, 2022	SELL	$15.36 - $27.51 $567,060 - $1.02 Million	-36,918 Reduced 80.56%	8,908 $221,000
Q3 2021 Nov 15, 2021	SELL	$13.18 - $19.83 $4.42 Million - $6.64 Million	-335,085 Reduced 87.97%	45,826 $784,000
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $1.47 Million - $7.82 Million	153,638 Added 67.6%	380,911 $5.1 Million
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $23.3 Million - $32.1 Million	-469,821 Reduced 67.4%	227,273 $11.6 Million
Q4 2020 Feb 16, 2021	SELL	$47.25 - $65.16 $3.61 Million - $4.98 Million	-76,376 Reduced 9.87%	697,094 $43.2 Million
Q3 2020 Nov 16, 2020	BUY	$46.35 - $61.69 $30.2 Million - $40.2 Million	650,920 Added 531.15%	773,470 $42.4 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $3.88 Million - $6.54 Million	100,482 Added 455.33%	122,550 $7.05 Million
Q1 2020 May 15, 2020	SELL	$32.73 - $50.78 $389,585 - $604,434	-11,903 Reduced 35.04%	22,068 $887,000
Q4 2019 Feb 14, 2020	SELL	$6.81 - $39.55 $132,427 - $769,089	-19,446 Reduced 36.4%	33,971 $1.34 Million
Q3 2019 Nov 14, 2019	SELL	$6.47 - $8.96 $257,460 - $356,545	-39,793 Reduced 42.69%	53,417 $363,000
Q2 2019 Aug 14, 2019	SELL	$8.31 - $14.85 $275,468 - $492,262	-33,149 Reduced 26.23%	93,210 $867,000
Q1 2019 May 15, 2019	SELL	$10.01 - $13.89 $886,285 - $1.23 Million	-88,540 Reduced 41.2%	126,359 $1.76 Million
Q4 2018 Feb 14, 2019	SELL	$9.15 - $12.26 $411,182 - $550,939	-44,938 Reduced 17.29%	214,899 $2.34 Million
Q3 2018 Nov 14, 2018	SELL	$10.49 - $13.72 $174,312 - $227,985	-16,617 Reduced 6.01%	259,837 $3.29 Million
Q2 2018 Aug 14, 2018	SELL	$10.62 - $13.98 $811,506 - $1.07 Million	-76,413 Reduced 21.65%	276,454 $3.64 Million
Q1 2018 May 15, 2018	BUY	$5.9 - $14.99 $559,845 - $1.42 Million	94,889 Added 36.78%	352,867 $4.8 Million
Q4 2017 Feb 14, 2018	BUY	$5.53 - $8.42 $68,256 - $103,928	12,343 Added 5.02%	257,978 $1.54 Million
Q3 2017 Nov 14, 2017	BUY	$6.5 - $10.69 $1.6 Million - $2.63 Million	245,635	245,635 $1.82 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.